COMPOSITION FOR THE PREVENTION AND TREATMENT OF FATTY LIVER DISEASES CONTAINING HONOKIOL AS AN ACTIVE INGREDIENT

摘要

Provided is a composition for prevention or treatment of fatty liver diseases by employing honokiol capable of increasing activity of PPAR-alpha which controls synthesis of an enzyme related to oxidation of fat. A composition for prevention or treatment of fatty liver diseases comprises honokiol represented by the formula 1 as an active ingredient. The honokiol is separated from a silver magnolia and refined. The Honokiol suppresses activity of SREBP-1 which controls synthesis of an enzyme related to biosynthesis of fat. A method for separating the Honokiol consists of a step of dispersing a 70% ethanol extract solution of dried stems of the silver magnolia in water.